Enter assignee name

EPO Patents = 2

Forward Citations = 18

Loading Chart...

8 inventors (with patents filed for the assignee):

Yaron R Hadari (12 out of 23 patents)

Luca Carta (12 out of 13 patents)

Theresa M Williams (12 out of 60 patents)

4. Michael Schmertzler (12 out of 17 patents)

5. Charles Howard Reynolds (12 out of 48 patents)

6. Rebecca Hutcheson (9 out of 9 patents)

7. Carolina Bigarella (1 out of 1 patent)

8. Sufang Zhang (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 12459951 - Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease (2025-11-04),

2. 12391705 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease (2025-08-19),

3. 12168668 - Compounds for the treatment of cancer and inflammatory disease (2024-12-17),

4. 11560390 - Compounds for the treatment of cancer and inflammatory disease (2023-01-24),

5. 11541041 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease (2023-01-03),

6. 11213515 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease (2022-01-04),

7. 11026930 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease (2021-06-08),

8. 11000515 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease (2021-05-11),

9. 10940139 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease (2021-03-09),

10. 10933054 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease (2021-03-02),

11. 10870657 - Compounds for the treatment of cancer and inflammatory disease (2020-12-22),

12. 10588894 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease (2020-03-17),

Shy Therapeutics LLC is a biopharmaceutical company focused on developing innovative therapeutics for the treatment of rare genetic diseases. With a team of experienced scientists and researchers, Shy Therapeutics is dedicated to improving the lives of patients by discovering and delivering novel treatments. Our mission is to bring hope and healing to those affected by these challenging conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

12 Patents

#3 in Harrison, NY

#1,386 in New York

#24,841 in US

#46,762 in the World

Harrison, NY, United States of America

Shy Therapeutics LLC